On June 21, 2021, PMG Pharmascience Co., Ltd. (KOSDAQ:A073570) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,930 KRW | +0.17% | -0.17% | -16.05% |
05-30 | JW (Cayman) Therapeutics Presents Trial Data from SLE Drug at Rheumatology Congress | MT |
05-14 | JW Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
131,000 KRW | -2.09% | +3.48% | 2.57B | ||
7,290 KRW | +1.11% | -2.80% | 2.78B | ||
4,470 KRW | -2.08% | -13.04% | 117M | ||
4,240 KRW | +2.79% | -1.40% | 284M | ||
1st Jan change | Capi. | |
---|---|---|
-16.05% | 154M | |
+16.72% | 41.95B | |
+21.78% | 22.53B | |
+14.89% | 14.91B | |
+18.03% | 14.11B | |
+48.66% | 12.5B | |
-9.26% | 6.75B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.55% | 5.6B |
- Stock Market
- Equities
- A096760 Stock
- News JW Holdings Corporation
- PMG Pharmascience Co., Ltd. announced that it has received KRW 15 billion in funding from Eugene Investment & Securities Co.,Ltd., JJ Assets Co., Ltd., Mirae Asset Securities Co., Ltd., JW Holdings Corporation, Kiwoom Securities Co., Ltd.